| Donald H Batts, MD | |
|
363 Fremont St, Suite 305, Battle Creek, MI 49017-3389 | |
| (269) 245-8302 | |
| (269) 245-8309 |
| Full Name | Donald H Batts |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Infectious Disease |
| Location | 363 Fremont St, Battle Creek, Michigan |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083683171 | NPI | - | NPPES |
| 4275181 | Medicaid | MI | |
| 4403900241 | Other | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 4301035194 (Michigan) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Donald H Batts, MD 363 Fremont St, Suite 305, Battle Creek, MI 49017-3389 Ph: (269) 245-8302 | Donald H Batts, MD 363 Fremont St, Suite 305, Battle Creek, MI 49017-3389 Ph: (269) 245-8302 |
News Archive
The study, published in the journal Cell Reports, showed that the mutations in the virus, particularly the deletion of two amino acids H69/V70 seen in the Alpha variant (B.1.1.7), enables the virus to overcome weaknesses as it evolves.
OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that it has applied for the voluntary delisting of OXiGENE common shares from the Stockholm Stock Exchange (SSE). The company will continue to be listed on the NASDAQ Global Markets exchange.
The President of the Texas Health Care Association (THCA), Tim Graves, today expressed concern about the growing cumulative pressure on the critical state and federal funding needed to preserve and protect Texas' most vulnerable nursing home residents. Specifically, Graves warned that sharp federal Medicare cuts already put in place by the Obama Administration in late 2009 – as well as those contained within the pending federal health care reform bill – must be a key consideration as state lawmakers begin assessing budgetary priorities in the face of looming state budget deficits.
More than half of patients with bipolar disorder fail to take their medication as prescribed, a study of Finnish inpatients and outpatients has found.
Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has launched an over-the-counter (OTC) pain reliever, Cobroxin, for the treatment of Stage 2 (moderate to severe) chronic pain.
› Verified 5 days ago
Dr. Ireneo Yap Diaz Jr., M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 5500 Armstrong Rd, Battle Creek, MI 49015 Phone: 269-966-5600 Fax: 269-660-6041 | |
Dr. Thomas F. Ignaczak, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 363 Fremont St Ste 203, Battle Creek, MI 49017 Phone: 269-969-6123 Fax: 269-969-6122 | |
Samir Bateriwala, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 5500 Armstrong Rd, Battle Creek, MI 49037 Phone: 269-966-5600 | |
Eric John Smith, DO Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 363 Fremont St Ste 100, Battle Creek, MI 49017 Phone: 269-245-5100 | |
Mrs. Ashley Marie Fugate, FNP-BC Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 181 Emmett St W, Battle Creek, MI 49037 Phone: 269-965-8866 | |
Shekhar C Thakur, MD Infectious Disease Medicare: Not Enrolled in Medicare Practice Location: 231 North Ave, Battle Creek, MI 49017 Phone: 269-565-1111 Fax: 269-565-1900 |